Human neuroserpin : structure and time-dependent inhibition by S. Ricagno et al.
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
467
48
4950
51
52
53
54
55
56
57
58
59
ARTICLE IN PRESS
ZRT YJMBI-61252; No. of pages: 13; 4C: 4, 5, 7, 8
doi:10.1016/j.jmb.2009.02.056 J. Mol. Biol. (2009) xx, xxx–xxx
Available online at www.sciencedirect.comHuman Neuroserpin: Structure and
Time-Dependent Inhibition
Stefano Ricagno1†, Sonia Caccia2†, Graziella Sorrentino1,
Giovanni Antonini3 and Martino Bolognesi1⁎CT1Department of Biomolecular
Sciences and Biotechnology,
CNR-INFM and CIMAINA,
University of Milano, Via
Celoria 26, 20133 Milan, Italy
2Department of Biomedical
Sciences and Technology,
University of Milano, Via F.lli
Cervi 93, I-20090 Segrate (MI),
Italy
3Department of Biology,
Interdepartmental Laboratory of
Electronic Microscopy,
University of Roma “Tre”, Viale
Marconi 446, I-00146 Rome,
Italy
Received 21 January 2009;
received in revised form
19 February 2009;
accepted 24 February 2009U
*Corresponding author. E-mail addr
martino.bolognesi@unimi.it.
† S.R. and S.C. contributed equall
Abbreviations used: hNS, human
tissue plasminogen activator; RCL, r
FENIB, familial encephalopathywith
bodies; IPR-pNA, H-D-Ile-Pro-Arg-p
plasminogen activator inhibitor-1; VR
region-1; EFK-pNA, Pyro-Glu-Phe-Ly
0022-2836/$ - see front matter © 2009 P
Please cite this article as: Ricagno, S.
doi:10.1016/j.jmb.2009.02.056D P
RO
OF
Human neuroserpin (hNS) is a protein serine protease inhibitor expressed
mainly in the nervous system, where it plays key roles in neural
development and plasticity by primarily targeting tissue plasminogen
activator (tPA). Four hNS mutations are associated to a form of autosomal
dominant dementia, known as familial encephalopathy with neuroserpin
inclusion bodies. The medical interest in and the lack of structural
information on hNS prompted us to study the crystal structure of native
and cleaved hNS, reported here at 3.15 and 1.85 Å resolution, respectively.
In the light of the three-dimensional structures, we focus on the hNS
reactive centre loop in its intact and cleaved conformations relative to the
current serpin polymerization models and discuss the protein sites hosting
neurodegenerative mutations. On the basis of homologous serpin struc-
tures, we suggest the location of a protein surface site that may stabilize the
hNS native (metastable) form. In parallel, we present the results of kinetic
studies on hNS inhibition of tPA. Our data analysis stresses the instability of
the hNS–tPA complex with a dissociation half-life of minutes compared to a
half-life of weeks observed for other serpin–cognate protease complexes.E © 2009 Published by Elsevier Ltd.EKeywords: FENIB; neuroserpin; neurodegeneration; protein protease inhibitor;tissue plasminogen activatorEdited by R. Huber R
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ORIntroductionHuman neuroserpin (hNS), a member of the serpin(serine protease inhibitor) superfamily,1 is mainly
expressed in neurons, but hNS mRNA has been
detected in the pancreas, heart, and testis.1,2 Human
neuroserpin (SERPINI1 according to the accepted
serpin nomenclature3) is a secretory protein that
exerts its recognized physiological role in axonogen-
esis and synaptogenesis, during development and in70
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et al., Human Neuroserpin:synaptic plasticity in the adult, both as an inhibitor
of tissue-type plasminogen activator (tPA) and in a
tPA-independent way.1,2,4,5 In Alzheimer's disease
models, hNS has been found to interact with the β-
amyloid (Aβ) peptide with remarkable effects: first,
interaction with Aβ depresses the hNS protease
inhibitory activity, and second, Aβ amyloid aggre-
gation is enhanced. Moreover, in cell lines and in a
Drosophila model, hNS exerts a protective role
against the toxicity of Aβ peptide aggregates.6
Serpins are ubiquitous proteins (composed of 350–
450 amino acids) whose fold is conserved through the
phyla.3 Their tertiary structure is characterized by
threeβ-sheets (A, B, andC), ninemainα-helices, and a
long exposed flexible loop, the reactive centre loop
(RCL),3,7 which binds to the target protease active site.
When the serpin–protease inhibitory complex is
achieved, the protease recognizes the RCL as a
pseudo-substrate and cleaves it at the P1–P1′ peptide
bond,8 with formation of a covalent acyl–enzyme
adduct. RCL cleavage triggers amajor conformationalStructure and Time-Dependent Inhibition, J. Mol. Biol. (2009),
C81
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change within the serpin molecule; before hydrolysis
of the acyl–enzyme, the RCL upstream of the scissile
bond is inserted between strands 3 and 5 of the A β-
sheet as strand 4 (s4A; strands and helices are
identified by the “s” and “h” suffixes, respectively).
As a consequence, the protease, covalently bound to
the P1 residue, is transferred to a serpin surface region
(about 70Å away) opposite to the location of the intact
RCL. Such extensive structural changes result in
inhibition of the protease through deformation of the
catalytic triad that dramatically slows the deacylation
step (typically weeks).9 The hNS–tPA inhibitory
interaction, however, differs from such a general
scheme in that the acyl–enzyme intermediate is
relatively short-lived.10
In addition to native and cleaved states, selected
serpins are known to adopt an inactive “latent”
conformation where, in the absence of proteolytic
cleavage, the intact RCL is fully inserted into sheet A
as s4A (for a review, see Ref. 11). Several pieces of
evidence show that in selected serpins the stability
of the native versus the latent form can be increased
by the interaction with polypeptides binding to the
s1A and hE regions. Plasminogen activator inhibi-
tor-1 (PAI-1) converts into the latent state if the
cofactor protein vitronectin is unavailable,12 and the
bacterial serpin tengpin adopts native or latent
forms depending on the intramolecular interaction
of its N-terminal region with the s1A-hE motif.13
The first disease shown to be associated to serpin
polymerization was discovered in 1992 and was
related to an unstable form of α1-antitrypsin, which
accumulates as polymeric aggregates in hepato-
cytes, eventually leading not only to cirrhosis but
also to lung emphysema, α1-antitrypsin being a
natural inhibitor of neutrophil elastase.14 Two
aspects of pathology are therefore related to serpin
polymerization: the damage occurring at a local
level due to polymer accumulation at the site of
protein synthesis, and more general effects resulting
from a distributed lack of serpin inhibitory activity.
It is now recognized that different serpins can form
long linear polymers, leading to intracellular accu-
mulation and diseases, collectively reported as
“serpinopathies”.1,15 The structural bases for serpin
polymerization have been under scrutiny for more
than 15 years, resulting in two primary models, both
essentially based on swapping of protein elements
and on the instability of the main serpin β-sheet. On
one hand, it was proposed that formation of
polymeric serpin would involve the repeated
incorporation of part of the RCL from one molecule
into the A β-sheet of the following one.14 On the
other hand, based on the crystal structure of a
dimeric form of antithrombin, a model has been
recently proposed whereby iterative domain swap-
ping, based on the intermolecular exchange of
strands s4A and s5A, would lead to formation of a
string of domain-swapped latent molecules.16,17
Such a model requires a partially unfolded poly-
merogenic intermediate (M⁎) whose helix I, strand
s5A, and the connecting loop are unstructured and
solvent-exposed.16 The M⁎ intermediate would thenPlease cite this article as: Ricagno, S. et al., Human Neuroserpin:
doi:10.1016/j.jmb.2009.02.056TE
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associate with linear polymers by inserting part of its
unstructured region (equivalent of two β-strands)
into a widened A β-sheet of the neighboring
molecule. Both models agree on the fact that serpin
polymers are composed of individual protein mole-
cules that retain much of their native state, different
from amyloid fibrils, where a considerable level of
native protein unfolding is held to be present.
Human neuroserpin is responsible for a polymer-
ization-linked severe neurodegenerative disease,
known as familial encephalopathy with neuroserpin
inclusion bodies (FENIB).1,15 Four pathological hNS
single-site mutants have been described (S49P, S52P,
H338R, and G392E) and are associated with various
levels of dementia, progressive myoclonus epilepsy,
dysarthia, and chorea.18 They are held to enhance
hNS propensity to polymerize and form bulky
deposits in the endoplasmic reticulum and
lysosomes.19–21 The mutations correlate with in vitro
polymerization rates, the extent of brain inclusions,
and different levels of disease severity, with the
earliest FENIB onset (associated to the G392E
mutant) being typical of the first decade of life.22
Despite the considerable medical interest in hNS,
to date only a 3.06 Å resolution structure of cleaved
mouse neuroserpin has been reported.23 Such lack of
direct structural information prompted us to inves-
tigate the crystal structures of hNS in its native and
cleaved forms, reported here at 3.15 and 1.85 Å
resolution, respectively. Moreover, although the
instability of the hNS–tPA complex over time had
been previously recognized, the relative lack of
kinetic studies taking into account the limited
temporal stability of the complex for the analysis
of the data led us to reconsider an investigation on
tPA inhibition kinetics. The main molecular proper-
ties of hNS, such as RCL flexibility, RCL-dependent
intermolecular interactions, potential interaction
sites, the effects of FENIB mutations on hNS
stability, and the hNS transient inhibitory process,
are discussed in the light of the reported results.Results
Overall fold of native neuroserpin
Human neuroserpin has been crystallized (as the
intact active metastable form, residues 1–410) in the
orthorhombic I222 space group, with five molecules
per asymmetric unit (chains A through E). The
crystal structure of native hNS has been solved at
3.15 Å resolution, yielding a good-quality model as
judged by commonly accepted criteria (see Table 1).
Interpretable electron density is available, with
some local discontinuities, for amino acids Pro22
through Met 400, for all five independent molecules.
As for all known serpins crystallized in the native
metastable form, hNS displays the typical serpin
fold composed of three large β-sheets and nine α-
helices; sheet A consists of five β-strands, while
the RCL (between strands s3A and s1C) largelyStructure and Time-Dependent Inhibition, J. Mol. Biol. (2009),
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Table 1t1:1 . Data collection and refinement statistics for
native and cleaved hNS structurest1:2
t1:3 Native hNShuman
neuroserpin
Cleaved hNShuman
neuroserpin
t1:4 Beam line ESRF ID14-2 ESRF ID14-1
t1:5 Space group I222 P21212
t1:6 Unit cell (Å) a=171.8, b=179.2,
c=248.2
a=72.93, b=100.06,
c=115.82
t1:7 Solvent content (%) 75 55
t1:8 Resolution (Å) 20–3.15 40–1.85
t1:9 Rsym (%) 12.9 (83.4) 9.9 (65.8)
t1:10 I/σI 10.3 (1.9) 12.7 (2.7)
t1:11 Completeness (%) 99.6 (100.0) 99.9 (99.9)
t1:12 Redundancy 4.1 (4.2) 7.1 (6.5)
t1:13 Unique reflections 66,051 78,887
t1:14
t1:15 Refinement
t1:16 Rwork (%) 23.5 19.2
t1:17 Rfree (%) 28.6 23.9
t1:18 No. of atoms
t1:19 Protein atoms 14,432 5882
t1:20 Water molecules — 541
t1:21 Ramachandran plot
t1:22 Most favoured
region (%)
92.6 96.35
t1:23 Allowed region (%) 2.5 3.22
t1:24 Outliers (%) 1.4 0.44
Values in parentheses are for the highest-resolution shells: 3.15–3.32
and 1.85–1.95 Å.t1:25
aRmerge=∑|I− 〈I〉|/∑|I|, where I is the observed intensity and
〈I〉 is the average intensityQ1 .t1:26
bRwork=∑hkl||Fo|−∣Fc||/∑hkl|Fo∣for all data except 5% that
were used for Rfree calculation.t1:27
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protrudes from the protein core, showing no interac-
tion with sheet A (Fig. 1a).
In all five independent hNS molecules (Fig. 1c) no
electron density is observed for the loops located
between helices hC and hD (residues 79–85) and
between strands s1B and s2B (residues 231–238).
Helix hD can be unambiguously traced; however,
the electron density is of poor quality and its higher
than average B-factors reflect particular flexibility or
local disorder. Except for chain B, all the other four
hNS chains show incomplete electron density for
their RCLs. In particular, chain E displays poorer
electron density relative to the other four indepen-
dent molecules, probably due to its contained
contacts within the crystal lattice (Supplementary
data). The five hNS chains display very similar
overall conformations: molecules A, B, D, and E
superpose with an RMSD lower than 0.6 Å (Table 2)
calculated over the whole Cα backbone, with the
exclusion of the RCLs whose conformations vary in
the five independent hNS molecules (Fig. 1d).
Structural superposition of the hNS C chain on the
other four chains results in slightly higher RMSDs
(0.7–0.8 Å) due to the different conformations
adopted by helices hG and hH in chain C (Table 2
and Supplementary data).
Crystal packing of native neuroserpin
The five independent hNS molecules hosted in the
crystal asymmetric unit are held together mainly viaPlease cite this article as: Ricagno, S. et al., Human Neuroserpin:
doi:10.1016/j.jmb.2009.02.056TE
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RCLs and the C β-sheet, being assembled in a star-
like pentamer at the centre of which the RCLs
converge and are partly solvent-inaccessible (Fig.
1c). The RCL hosts several low-polarity residues (15
out of 20) whose hydrophobic association (particu-
larly in the C-terminal half of the RCL) is likely
driving the association to the observed pentamer.
On the other hand, RCL hydrophobicity may also be
one of the factors promoting hNS polymeric
aggregation, since, according to the current models,
linear hNS polymers require partial insertion of part
of the RCL in the A sheet of a neighboring hNS
molecule.11
Reactive centre loop
Each RCL in the five independent hNS chains
displays a different conformation (Fig. 1d), such that
none of the five RCLs can be properly superposed
on any other. The N-terminal part of all five RCLs
(residues 348–357) does not establish intra/inter-
molecular interactions, in keeping with the confor-
mational disorder observed for this stretch in chains
C and E. The C-terminal part of all RCLs is instead
buried in the pentamer association centre (Fig. 1c)
and clearly defined in the electron density.
The C-terminal part of chain A RCL is of particular
interest since strand s1C extends into the RCL
(residues 363–367), establishing intermolecular
hydrogen bonds with a similarly elongated s1C
strand from molecule D (residues 365–368).
Together with residues 227–230 of chain C (i.e.,
s1B) they form an intermolecular, antiparallel, three-
stranded β-sheet that helps to stabilize part of the
pentameric assembly (Supplementary data).
Human neuroserpin chain B shows interpretable
electron density for the whole RCL, whose C-
terminal part interacts with strand s1C from chain
C, with residues 259–261 from chain A (s3B-hG
loop), and with the RCL from chain D (residues 363–
373). Similarly, the interactions between the RCL
from chain B (364–367) and the RCL from chain D
(360–362) result in β-like intermolecular structure.
The above observations show that the RCL sequence
allows wide conformational variability and stress
the RCL's strong adaptability to intermolecular
interactions that may also find partners other than
the hNS A sheet.
s1A intermolecular interactions
An elongated electron density feature extending
for about 12 Å is visible adjacent to strand s1A for
every native hNS chain, being of particularly good
quality in chain B. The extra density can be properly
fitted by residues 400–407 from the C-terminus of
the B chain from a symmetry-related pentamer
(Fig. 2). The interaction between s1A and the C-
terminus of an adjacent chain is reminiscent of
what has been observed for tengpin and for PAI-1,
where interactions of s1A with the N-terminus (in
tengpin) and with vitronectin (in PAI-1) stabilize the
native metastable serpin conformation versus theStructure and Time-Dependent Inhibition, J. Mol. Biol. (2009),
UN
CO
RR
EC
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OF
Fig. 1 (legend on next page)
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290
291
292
293
294
295
296
Fig. 1. (a) Cartoon representation of native hNS (chain B). Sheet A is shown in yellow, sheet B in blue, and sheet C in
cyan. α-Helices are red and loops are green. (b) Cartoon representation of cleaved hNS coloured as in (a); the RCL inserted
into sheet A is green. (c) Cartoon representation of hNS crystallographic pentamer. The RCLs are located at the centre of
the pentameric assembly. For reference, when visible in the drawn chains, helix F (hF) and sheet A (sA) are labelled. (d)
Cartoon representation of part of the five superposed hNS chains (grey) neighboring the RCL region; chain A RCL is
shown in red, chain B in green, chain C in blue, chain D in yellow, and RCL E in magenta.
5Neuroserpin Structure and Inhibition
ARTICLE IN PRESSlatent form.12,13 Such finding may suggest that the
s1A region requires stabilization for hNS to main-
tain the native metastable conformation (stable for
weeks at 20 °C before crystallization occurs).Please cite this article as: Ricagno, S. et al., Human Neuroserpin:
doi:10.1016/j.jmb.2009.02.056Overall structure of cleaved neuroserpin
The structure of trypsin-cleaved hNS was solved
and refined at 1.8 Å resolution (Rwork 19.2%, RfreeStructure and Time-Dependent Inhibition, J. Mol. Biol. (2009),
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Table 2t2:1 . RSMD values calculated between native hNS
chains A–Et2:2
t2:3 A (364) B (376) C (358) D (361) E (340)
t2:4 A — 0.6 Å (350) 0.75 Å (330) 0.44 Å (355) 0.47 Å (333)
t2:5 B — 0.85 Å (327) 0.64 Å (352) 0.49 Å (330)
t2:6 C — 0.72 Å (328) 0.80 Å (320)
t2:7 D — 0.46 Å (330)
t2:8 E —
The number of Cα atoms for each chain is in parentheses in the top
row. The number of Cα atoms used to calculate each RSMD value
is specified for each comparison.t2:9
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23.9%) (Table 1). The three main β-sheets and nine α-
helices typical of other cleaved serpins are readily
recognized in the proteolyzed hNS structure
(Fig. 1b). The two hNS chains hosted in the
asymmetric unit are structurally very similar, with
an RMSD of 0.31 Å calculated over the whole Cα
backbone. Both independent chains were unambigu-
ously traced in the electron density between residues
24 and 400, with only a few gaps of low or absent
electron density. Interestingly, helix hD is only
partially visible, is characterized by higher than
average B-factors (about 35 Å2), and is isolated
from the rest of the molecule by two electron density
gaps (81–85 and 94–102). Notably, the Peptide Cutter
server‡ predicts two highly probable trypsin clea-
vage sites in the two gap regions. It is possible that
hD, even if cleaved, can be non-covalently associated
with the rest of the hNS molecule; however, it should
be recalled that hD displays poor electron density
also in the native hNS structure.
As expected, the RCL is cleaved at residue 362
and inserted in the A β-sheet as β-strand 4
(residues 347–361). Arg362, the P1 RCL residue,
can be recognized at the lower edge of β-sheet A
(Fig. 1b). The C-terminal part of the cleaved RCL
(residues 365–368) remains located next to the site it
occupies in the uncleaved hNS, being stabilized by
crystal contacts to the distal part of sheet A from a
symmetry-related chain.
A DALI search shows that the cleaved serpin
structure most similar to hNS is antithrombin III,
with an RMSD of 1.3 Å for 351 of 410 Cα pairs
[Protein Data Bank (PDB) code 1ATT]. Cleaved PAI-
1 shows an RMSD of 2.1 Å for 352 of 379 Cα pairs
(PDB code 9PAI). Conversely, the superposition
between cleaved hNS and α1-antitrypsin in complex
with trypsin (PDB code 1EZX) yields an overall
RMSD of 1.47 Å for 309 Cα pairs, and the region
interacting with trypsin shows the lowest RMSD.
Neuroserpin inhibitory activity
The hNS inhibitory activity on tPA was analyzed
by means of a chromogenic assay using the tPA
substrate H-D-Ile-Pro-Arg-p-nitroanilide (IPR-pNA).
Serpins typically show inhibition progress curves401
402
403‡http://www.expasy.ch
Please cite this article as: Ricagno, S. et al., Human Neuroserpin:
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characteristic of slow-binding inhibitors, reaching a
plateau after pre-steady-state release of the product,
as expected for an irreversible inhibitory complex.24,25
On the contrary, immediately following the initial
phase typical of slow-binding inhibitors, the progress
curves for the hydrolysis of IPR-pNA by tPA in the
presence of hNS show a progressive increase in the
rate of substrate hydrolysis (Fig. 3a), revealing a
recovery of tPA activity after transient inhibition by
hNS. Such behavior suggests instability of the hNS–
tPA acyl–enzyme complex, with functional tPA
rescue following deacylation. Fitting of the progress
curves by numerical integration according to the
mechanism drawn in reactions 1 and 2 [Eq. (1)]
yielded a kinh value of (2±0.06)×105 M−1 s−1, with a
rate constant of (1.2±0.03)×10−3 s−1 for complex
breakdown, corresponding to a dissociation half-life
of about 10 min. Thus, despite a relatively efficient
rate of inhibition, hNS cannot be considered a stable
tPA inhibitor. Such peculiar instability of the hNS–
tPA complex, compared to the much longer half-life
of other serpin–protease complexes (usually weeks),
had previously been reported.10,26 Notably, however,
the models previously used for fitting the experi-
mental data did not take into account the recovery of
protease activity, describing only the initial part of
the reaction (the build-up of inhibition), thus leading
to rate constant values quite different from those
reported here.2,5,26
To complement the above data analysis with an
independent assessment, the products of the hNS–
tPA reaction were separated and quantified by SDS-
PAGE, followed by fluorescent staining (Fig. 3b).
Such an approach showed that the serpin–protease
complex band (∼75 kDa) remained stable for an
initial period of time, after which it gradually started
to fade away. In parallel, a decrease in intensity of
the intact hNS band (∼45 kDa) and an increase of a
∼40-kDa band corresponding to cleaved hNS were
observed, suggesting the ongoing hNS–tPA complex
deacylation. All the hNS present was eventually
cleaved with no evidence of residual latent hNS
form. The fluorescence intensity data corresponding
to the intact, complexed, and cleaved hNS were
interpolated according to the neuroserpin inhibition
mechanism (Materials andMethods; reaction 1). The
resulting rate constant values matched quite satis-
factorily those obtained from the chromogenic
assays, such that a common set of values for the
rate constants was obtained (Supplementary data).
The chromogenic and SDS-PAGE assays were
completely reproducible when the protease domain
of tPA alone was used (data not shown), suggesting
that the short-lived stability of the acyl–enzyme
complex is not due to the tPA light chain preventing
insertion of the RCL into sheet A, thus hampering
protease translocation after the P1–P1′ bond cleavage.
Lastly, in order to combine the transient nature of
hNS inhibitory activity with tPA physiological
activation of plasminogen, we performed an indirect
assay in which plasminogen activation by tPA in the
presence of hNS was monitored via the hydrolysis
of a chromogenic substrate specific for plasmin. AsStructure and Time-Dependent Inhibition, J. Mol. Biol. (2009),
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Fig. 2. Stereo cartoon of the hF-s1A-hE region from molecule B in the native hNS structure, coloured according to
secondary structures. The C-terminus from the symmetry-related molecule B⁎, shown as purple sticks, interacts with s1A.
In particular, the side chain of His 405 is inserted between hF and s1A.
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due to the presence of hNS, although the serpin is
readily cleaved by both tPA and plasmin (Supple-
mentary data).C
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Discussion
Here we report the first X-ray structural char-
acterization of hNS. Two main hNS forms are
described: the native active hNS, at 3.15 Å resolu-
tion, showing an intact, solvent-exposed RCL, and
the cleaved form, at 1.85 Å resolution, showing the
RCL upstream of the P1–P1′ cleavage site inserted in
sheet A.
Native hNS is observed in the crystal lattice as a
pentameric assembly whose core buries part of each
RCL, providing most of the pentamer-stabilizing
intermolecular (hydrophobic) interactions. Within
the pentamer, the individual hNS chains display
interaction surfaces (average, 11.2% of the total
chain surface) much larger than “interpentameric”
interaction surfaces (about 5.8%), suggesting the
pentamer role as the crystal lattice building block
(Supplementary data). Despite the tendency of hNS
solutions to yield higher-order polymeric species
with aging, hNS crystals have been obtained in our
laboratory under more than 20 non-redundant
crystallization conditions over periods of weeks.
All hNS crystals display the same morphology, and
all the crystals tested share the same orthorhombic
space group and unit cell constants (Table 1),
indicating that the pentameric assembly is main-
tained under several different hNS crystallization
conditions.
Various examples of RCL ability to form inter-
molecular β-like interactions are observed in the
hNS native structure. RCLs from chains A and D
together with strand s1B from chain C form a three-Please cite this article as: Ricagno, S. et al., Human Neuroserpin:
doi:10.1016/j.jmb.2009.02.056TE
D P
Rstranded β-sheet (Supplementary data). RCLs from
chains D and B also establish β-like interactions. All
such intermolecular interactions have important
implications: (i) RCL displays evident propensity
to form β-strands outside sheet A; (ii) RCL hydro-
phobicity and tendency to form β structure promote
intermolecular RCL interactions; (iii) by using the
intact RCL properties, hNS may assemble into
reversible (non-pathological) oligomers, that can
promptly release monomeric hNS for tPA inhibition.
It is worth noting that hNS is found in vivo to be
secreted in dense-cored secretory granules, where its
concentration is high and hNS is stored in a native
non-polymeric form.27
Recently, two serpins, PAI 1 and tengpin, have
been shown to host an allosteric site in the s1A-hE
region, where inter/intramolecular interactions con-
trol the switch between the latent and native
conformations.12,13 Sequence and structural com-
parisons show high levels of similarity between hNS
and tengpin in this region. In particular, three
residues shown to be relevant for the stability of
tengpin's native conformation are conserved, or
conservatively mutated, in hNS (tengpin/hNS:
Leu159/Leu125, Ile162/Met128, Ile170/Val136)
(Supplementary data). In the hNS native structure,
but not in the cleaved form, the C-termini of
symmetry-related molecules extensively interact
with s1A. The protein fragment ligated to s1A may
act as a constraint on the edge of sheet A and
prevent it from widening, thus hampering intramo-
lecular RCL insertion in the sheet (required for
switching to latent conformation). Such an interac-
tion, which would suggest the presence of an
allosteric site also in hNS, will require mutational
analyses and other experimental approaches to be
validated. It is, however, in keeping with the results
and structural interpretations reported for selected
serpins.12,13Structure and Time-Dependent Inhibition, J. Mol. Biol. (2009),
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Fig. 3. (a) Progress curves of the
hydrolysis of IPR-pNA (170 μM) by
tPA (1 nM) in the presence of hNS
(0, 15, 30, 60, and 120 nM). Inset:
close-up view of the reaction
between t=0 and 20 min. Symbols
represent the experimental data,
only part of which are indicated
for clarity. Continuous lines are
drawn according to the best-fit
parameter values obtained from
reactions 1 and 2. (b) hNS (1.6 μM)
was incubated with tPA (0.4 μM).
Band densities from SDS PAGE
(inset), expressed as concentrations,
were plotted against time: native
(circles), RCL-cleaved (triangles),
and complexed (diamonds) hNS.
Continuous lines are drawn accord-
ing to the best-fit parameter values
obtained from reaction 1. Inset: lane
1, molecular marker; lane 2, hNS;
lanes 3–11, 1-, 5-, 15-, 30-, 60-, 90-,
120-, 150-, and 180-min time points.
Native, RCL–cleaved, and com-
plexed (cpx) hNS bands are
shown. (c) Progress curves of the
hydrolysis of EFK-pNA (15 μM) by
plasmin (initial concentration of
plasminogen, 5 nM) following plas-
minogen activation by tPA (20 nM)
in the presence of increasing con-
centrations of hNS (200, 400,
800 nM). Symbols represent the
experimental data, only part of
which are drawn for clarity, and
the continuous lines are the fits of
the reactions 1, 3, 4, and 5 described
in Materials and Methods.
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Intriguingly, all the three neuroserpin structures
available to date (native and cleaved hNS from this
report and cleaved mouse neuroserpin23) show a
high degree of flexibility in the helix D region. The
complete lack of electron density for the C–D helix
region (residue 69–103) prompted us to speculate
that, in trypsin-treated mouse neuroserpin, the
protease cleaved other regions besides the P1 site,
thus removing the 69–103 residue stretch.23 Whether
cleaved or not visible in the crystal structure, the C–D
helix region is undoubtedly highly flexible in mouse
neuroserpin. In the cleaved hNS structure, helix D is
visible with short electron density gaps at the C- and
N-terminal ends, while in the native structure, such
helix is almost completely visible, but shows very
high average B-factors. In both hNS structures, the
loop connecting helix D to s2A is not defined by
electron density. Such flexibility might suggest that
this region is coded to bind a yet uncharacterized
ligand, as observed in other serpins.28
Four single-site hNS mutants have been reported
as associated with the FENIB pathological pheno-
type, with a direct correlation between the instability
of the mutant and the severity of the symptoms.18 All
four mutations (S49P, S52R, H338R, and G392E) are
known to promote polymerization. The four FENIB
mutated residues are strongly conserved throughout
the serpin superfamily (N90% conserved among all
serpin structures, from humans to bacteria, present in
the PDB). In the light of the recently proposed
polymerization model16 and considering the hNS
crystal structures here reported, the effect of the
pathological mutations can be rationalized (Supple-
mentary data).
As described earlier and further detailed here, the
kinetic behavior of the hNS–tPA complex differs
markedly from the virtually irreversible inhibitory
processes paradigmatically related to serpins. In
fact, more properly, it resembles a substrate hydro-
lysis process with a delayed intermediate. The
kinetic data analyzed here show that the half-life
of the cleaved hNS–tPA complex is only 10 min. An
immediate physiological consequence of this obser-
vation is that recognition of the hNS–tPA complex
by receptors must occur in a matter of minutes for
cellular internalization to take place. In fact,
although no direct evidence of the hNS–tPA com-
plex has been so far reported in vivo, cellular
internalization, a process mediated by LRP receptor
recognition, is observed in cell cultures both for
active hNS and for the hNS–tPA complex.29
From a structural viewpoint, transient inhibition of
tPA by hNS implies that the deformation of the
protease active-site region (preventing the deacyla-
tion reaction) may not be as dramatic in hNS–tPA as
reported for other serpin–protease complexes.9
However, structural comparison between cleaved
hNS and α1-antitrypsin in its covalent complex with
trypsin9 shows that the cleaved RCL is inserted in
sheet A in the very same fashion in the two serpins,
and the P1 residues (cleaved or linked to the
protease, respectively) fall in the same surface
locations. In this respect, recent reports havePlease cite this article as: Ricagno, S. et al., Human Neuroserpin:
doi:10.1016/j.jmb.2009.02.056TE
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shown that stable acyl complexes require full
insertion of the RCL,30,31 while short-lived acyl
complexes can be generated by improper RCL
length32 or by attractive interactions between the
serpin and the protease.33 Thus, the above observa-
tions suggest that the final conformation achieved by
the RCL in cleaved hNS is unlikely to be responsible
for the lower stability of the hNS–tPA complex.
The high affinity displayed by serpins for cognate
proteases is determined not only by the nature of
their P1 residue, but also by regions neighboring the
active site and the RCL on the interacting surfaces of
both macromolecules.34 The tPA variable region-1
(VR-1, or 37-loop), an exposed loop rich in positively
charged residues (Supplementary data), mapping
near one edge of the active site, was recognized to be
crucial for the interaction of tPA with PAI-1. The
region of PAI-1 interacting with tPA VR-1 has been
proposed to correspond to the negatively charged
residues in the RCL region C-terminal to the
cleavage site.35,36 Differently from PAI-1, hNS does
not display charged residues at that site; instead, a
strong negatively charged patch is present in hNS on
one side of β-sheet A (Supplementary data), which is
absent in PAI-1. Upon cleavage, the bound protease
must translocate toward the “lower rim” of the
serpin molecule. Electrostatic interactions between
the positive tPAVR-1 loop and the strongly negative
hNS surface may lead to a decreased rate of tPA
translocation. This would allow trapping of the hNS–
tPA acyl complex into a relative energy minimum
before the RCL is fully inserted into sheet A. Such
intermediate steps would allow the protease to retain
a structured active-site environment compatible with
acyl complex hydrolysis and dissociation.
As a whole, our results provide an overview of
hNS structural features and FENIB mutant instabil-
ity in the light of the recent polymer formation
theories, and provide foresight for mutational
analyses of the hNS sites that may support main-
tenance of the native metastable form. The kinetic
data presented, while in qualitative agreement with
previous results, stress the short half-life of the hNS–
tPA inhibitory complex, an uncommon property
among serpins that opens new questions on its in
vivo turnover.Materials and Methods
hNS expression and purification
The plasmid coding for hNS with an N-terminal His-tag
(kindly provided by Dr. Didier Belorgey, University of
Cambridge, UK) was transformed in Escherichia coli
Rosetta (DE3) pLys. Protein expression was carried out
in SB broth (Athena system) at 17 °C overnight. hNS was
purified by two-step chromatography. First, the crude
cellular extract was applied onto a Ni-NTA Sepharose
column (GE Healthcare) and hNS was eluted using a
buffer containing 50 mM Tris–HCl, 300 mM NaCl, and
250 mM imidazole (pH 8.0). Second, size-exclusion
chromatography was employed (Hi Load 16/60 SuperdexStructure and Time-Dependent Inhibition, J. Mol. Biol. (2009),
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and 1 mM DTT (pH 7.4) as elution buffer. hNS eluted as a
single peak with an apparent molecular mass of 45 kDa.663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682hNS crystallization
Crystallization trials were performed by sitting-drop
vapour-diffusion technique using an Oryx 8 crystalliza-
tion robot (Douglas Instruments, East Garston, UK) at
293 °K. hNS yielded crystal hits under 23 different
conditions. Optimization of crystal growth conditions
were carried out by manual sitting-drop experiments.
Crystals were grown by mixing equal volumes (1–2 μl) of
hNS (13 mg/ml) and precipitant solution. The best-
diffracting crystals appeared within 2 weeks in 1.4 M
ammonium sulfate and 0.1 M sodium cacodylate, pH 6.3
(293 °K). Before data collection, the crystals were flash-
frozen in liquid nitrogen with the use of a cryoprotectant
solution containing 25% glycerol in the crystallization
buffer. Data collection was performed at 110 K on beam
line ID14-2 at the European Synchrotron Radiation Facility
(ESRF) (Grenoble, France).C
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Native neuroserpin: structure determination
and refinement
X-ray diffraction data were processed with MOSFLM
and SCALA.37,38 A partial molecular replacement solution
was obtained with BALBES,39 which could locate four
hNS molecules, using human alpha1 antitrypsin as search
model. Notably, when the hNS sequence was used as
input to BALBES, the program failed to find a solution,
while forcing the use of alpha1 antitrypsin sequence
prevented BALBES to base the search model ensemble on
the murine-cleaved neuroserpin structure. Only after
thorough manual model building with COOT40 and
structure refinement with REFMAC541 did the electron
density for the fifth hNS molecule become apparent, and
the molecule was properly located by MOLREP.42
Restrained and ‘tls’ refinement procedures were applied.
Non-crystallographic symmetry restrains were applied to
all the five molecules, with the exception of the RCLs and
the 258–283 region of molecule C. Protein–protein inter-
action analysis was carried out through the PROTORP
server.43 R
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COLimited proteolysis and crystallization of cleaved hNSHuman neuroserpin at the concentration of 9 mg/mlwas incubated for 1 h at 37 °C with trypsin (Sigma),applying a 1:10 protease–hNS concentration ratio. The
proteolytic reaction was blocked by prompt addition of
soybean trypsin inhibitor (Sigma) at the final concentra-
tion of 3.3 mg/ml. Cleaved hNS was washed by size-
exclusion chromatography using a Sephadex 200 10/300
GL column (GE Healthcare) and by elution with 10 mM
Tris–HCl, 50 mM KCl, and 1 mM DTT (pH 7.4). Cleaved
hNS was concentrated to a final concentration of
13.8 mg/ml before crystallization. Crystallization trials
were performed using an Oryx 8 crystallization robot
(Douglas Instruments) at 293 K. Crystals of diffraction
quality were found in the F1 condition of Hampton
Research crystal screen [0.2 M ammonium sulfate, 0.1 M
sodium acetate (pH 4.6), 30% PEG (polyethylene glycol)
MME 2000] after 4 weeks. Crystals were flash-frozen
using their unmodified mother liquor as cryoprotectant.Please cite this article as: Ricagno, S. et al., Human Neuroserpin:
doi:10.1016/j.jmb.2009.02.056TE
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Cleaved hNS: structure determination and refinement
X-ray diffraction data were collected at the beam line
ID14-1 (ESRF Grenoble). Data were then processed
using MOSFLM and SCALA.37,38 One molecule of
cleaved mouse neuroserpin (PDB code 1JJO)23 was
adopted as search model for molecular replacement
using PHASER and MOLREP.42,44 Despite several trials,
both programs were able to locate only one of the two
expected asymmetric unit molecules. After refinement of
this partial solution (at 1.85 Å resolution), ARP-WARP45
was used to automatically build a 90% complete model
of the second chain; further manual model building was
then carried out using COOT.40 The cleaved hNS
structure was refined using REFMAC5, applying max-
imum likelihood residual, anisotropic scaling, bulk-
solvent correction, and atomic displacement parameter
refinement using the ‘tls’ method.41 Figures were pro-
duced using PyMOL§ and CCP4mg.46 The electrostatic
potential was calculated with PyMOL and APBS,47 where
solvent dielectric contribution (the dielectric constants
applied were 80 for the solvent and 8 and 4 for the
protein) was taken into account. The ionic concentration
was set to 0.15 M.
Determination of inhibition rate constants
The rate constants for the inhibitory reaction between
hNS and two-chain tPA (American Diagnostica) were
determined in the presence of the chromogenic substrate
IPR-pNA (Chromogenix) by analyzing the progress
curves for the formation of pNA upon cleavage of the
substrate. Experiments were performed at 298 K in 50 mM
Tris, 10 mM Na2HPO4, 150 mM NaCl, and 0.1% Tween
(pH 7.4). Buffer, inhibitor (15, 30, 60, 120, and 240 nM), and
substrate (170 μM) were mixed in a 2-ml cuvette and
reactions were initiated by addition of a fixed amount of
tPA (1 nM). Product accumulation was continuously
recorded by a Cary 4E spectrophotometer (Varian, Inc.)
at 405 nm. A typical experiment consisted of six assays
(one zero and five non-zero hNS concentrations). The
progress curve data were simultaneously fitted according
to the minimal kinetic scheme [Eq. (1)]:
tPA + hNS !k1
k1
hNS tPAYk2 hNS4=tPAYkbk tPA + hNS4 reaction 1
tPA + S !
TSKm tPA S !
TSKcat tPA + P reaction 2
ð1Þ
where hNS stands for human neuroserpin, hNS-tPA is the
Michaelis intermediate of the enzyme inhibitor interac-
tion, hNS⁎/tPA is the acyl–enzyme intermediate, and
hNS⁎ is the cleaved hNS.
The resulting system of rate equations was solved
through numerical integration by the software package
COPASI 4.4.27 without any need for approximations.48 A
parameter search was run to decouple the values of the
rates governing the hNS inhibitory reaction. The values of
the apparent second-order inhibition constant (kinh) and
the rate constant for acyl–enzyme complex breakdown
(kbk) were calculated. Values for the rates of IPR-pNA
hydrolysis were determined independently from the
experiments in the absence of hNS.Structure and Time-Dependent Inhibition, J. Mol. Biol. (2009),
C716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
7312
7334
7356
7378
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
11Neuroserpin Structure and Inhibition
ARTICLE IN PRESSUN
CO
RR
E
Plasminogen activation in the presence of
recombinant hNS
The rate of Lys-plasminogen (American Diagnostica)
activation by tPA in the presence of recombinant hNS was
measured by an indirect assay using a chromogenic
substrate specific for plasmin (Pyro-Glu-Phe-Lys-p-nitroa-
nilide, EFK-pNA). Buffer, hNS (200, 400, and 800 nM),
plasminogen (5 nM), and substrate (15 μM) were mixed in
a 2-ml cuvette and reactions were initiated by addition of a
fixed amount of tPA (20 nM). In this assay, the release of
pNA depends on four reactions: (1) the inhibition of tPA
by hNS (reaction 1), (2) the activation of plasminogen to
plasmin by tPA (reaction 3), (3) the cleavage of hNS by
plasmin (reaction 4), and (4) the cleavage of EFK-pNA by
plasmin (reaction 5):
tPA + hNS !k1
k1
hNS−tPAY
k2
hNS4=tPAY
kbk
tPA + hNS4 reaction 2
tPA + Plg !
TKm tPA−Plg !
TKcat tPA + PI reaction 3
PI +NS !
PKm PI−NS !
PKcat PI + NS4 reaction 4
PI + EFK−pNA !
PSKm PI−EFK−pNA !
PSKcat PI + pNA reaction 5
Under the chosen conditions, the progress curves of EFK-
pNA hydrolysis were very sensitive to the specificity
constant (kcat/Km) for plasminogen activation by tPA. The
reactions 1, 3, and 5 were studied directly in separate
experiments, and the rate constants obtained were
constrained in the global fitting. Analogously, no direct
hydrolysis of EFK-pNA by tPA was measured. The
kinetics of plasmin generation was then calculated.
Formation and deacylation of hNS⁎/tPA acyl–enzyme
complex
Samples at varying hNS versus tPA concentrations (6:1,
4:1, and 2:1 ratios) were incubated in the same buffer used
for the chromogenic assays. The reactions were stopped at
time intervals by addition of SDS sample buffer containing
β-mercaptoethanol followed by 10 min boiling. Products
and reagents were separated by SDS-PAGE analysis in
10% separating polyacrylamide gels. After electrophor-
esis, proteins were stained with SYPRO Ruby (Molecular
Probes), visualized by means of a Typhoon 9200 laser
scanner, and quantified with the ImageQUANT software
(GE Healthcare Life Science). SYPRO Ruby is an ultra-
sensitive fluorescent stain with a wide linear range for
protein quantization, which allowed an accurate quanti-
fication of the protein content of each band. The data
arising from the kinetics of intact, complexed, and cleaved
inhibitor were fitted according to reaction 1.
Protein Data Bank accession numbers
Atomic coordinates and structure factors for native and
cleaved hNS (PDB codes 3F5N and 3F02, respectively)
have been deposited with the PDB.∥∥http://www.rcsb.org
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